Clinical trial
Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
NCT02170519 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- January 31, 2009
- Enrollment
- 27 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary hypertension